Gepride M 3 Forte Tablet PR is a combination oral hypoglycemic agent containing Glimepiride 3 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, which enhances glucose uptake and utilization. The combination of these two agents provides complementary mechanisms of action, offering improved glycemic control in patients inadequately managed by diet, exercise, and monotherapy. Gepride M 3 Forte Tablet PR is typically prescribed when single-agent therapy is insufficient, and it is essential to monitor blood glucose levels regularly to adjust dosage and prevent hypoglycemia. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as the risk of hypoglycemia due to Glimepiride. Caution is advised in patients with renal or hepatic impairment, and contraindications include diabetic ketoacidosis and severe renal dysfunction. This medication should be used under medical supervision with appropriate lifestyle modifications to optimize therapeutic outcomes.

Dosage & How to Use